GLP1R and type 2 diabetes mellitus: This study aimed to investigate the potential cardioprotective effects of perioperative GLP-1 RA use in adult patients with T2DM and a history of CHD undergoing CABG, investigating one-, three-, six-, and 12-month outcomes.